Pancreatic Cancer Action

Last updated
Pancreatic Cancer Action
Founded2010 (2010)
FounderAli Stunt
Type Charitable organisation
Registration no.England and Wales: 1137689
Focus pancreatic cancer, Cancer research, Health policy
Location
  • 10 Oakhanger Business Park, Oakhanger, Hampshire, Hampshire, GU35 9JA
Area served
United Kingdom
Website www.pancreaticcanceraction.org

Pancreatic Cancer Action is a not-for-profit organisation based in the UK whose mission is to raise awareness of pancreatic cancer.

Contents

Founded by Ali Stunt, who is herself a rare survivor of the disease, [1] Pancreatic Cancer Action is dedicated to saving lives. The five-year survival rate for pancreatic cancer is only around 5% – this figure has not improved in over 40 years.

Pancreatic cancer is the fifth-commonest cause of cancer death in the UK yet receives only 1% of research funding. [2] Only 10% of patients with a diagnosis of pancreatic cancer are able to have potentially curative surgery. [3] [4]

One focus is the annual UK Pancreatic Cancer Awareness Month held in November each year.

Having been involved in setting up the very first Pancreatic Cancer Awareness Week in 2009, Ali Stunt decided it was time to step up the levels of awareness for pancreatic cancer and so founded Pancreatic Cancer Action.

Along with Stunt, Pancreatic Cancer Action has the support of many leading clinicians and researchers in the pancreatic cancer field, along with others whose lives have been touched by pancreatic cancer in some way.

The team

The Trustees

Medical advisors

Patrons

See also

Related Research Articles

Pancreatic cancer endocrine gland cancer located in the pancreas

Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to multiply out of control and form a mass. These cancerous cells have the ability to invade other parts of the body. There are a number of types of pancreatic cancer. The most common, pancreatic adenocarcinoma, accounts for about 90% of cases, and the term "pancreatic cancer" is sometimes used to refer only to that type. These adenocarcinomas start within the part of the pancreas which makes digestive enzymes. Several other types of cancer, which collectively represent the majority of the non-adenocarcinomas, can also arise from these cells. One to two percent of cases of pancreatic cancer are neuroendocrine tumors, which arise from the hormone-producing cells of the pancreas. These are generally less aggressive than pancreatic adenocarcinoma.

Surgical oncology is the branch of surgery applied to oncology; it focuses on the surgical management of tumors, especially cancerous tumors.

Pancreaticoduodenectomy major surgical procedure involving the pancreas, duodenum, and other organs

A pancreaticoduodenectomy, also known as a Whipple procedure, is a major surgical operation most often performed to remove cancerous tumours off the head of the pancreas. It is also used for the treatment of pancreatic or duodenal trauma, or chronic pancreatitis. Due to the shared blood supply of organs in the proximal gastrointestinal system, surgical removal of the head of the pancreas also necessitates removal of the duodenum, proximal jejunum, gallbladder, and, occasionally, part of the stomach.

Shaukat Khanum Memorial Cancer Hospital and Research Centre(Urdu: شوکت خانم میموریل کینسر ہسپتال اور تحقیق اداره‎, abbreviated as SKMCH&RC) is a cancer centre located in Lahore, Pakistan. It is the very first project of the Shaukat Khanum Memorial Trust, a charitable organization established under the Societies Registration Act XXI of 1860 of Pakistan. It is Pakistan's largest tertiary care cancer hospital.

The Norris Cotton Cancer Center is a comprehensive cancer center as designated by the National Cancer Institute, with administrative offices located within the Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire.

European Organisation for Research and Treatment of Cancer nonprofit organization

The European Organisation for Research and Treatment of Cancer (EORTC) is a unique pan-European non-profit clinical cancer research organisation established in 1962 operating as an international association under Belgium law. It develops, conducts, coordinates and stimulates high-quality translational and clinical trial research to improve the survival and quality of life of cancer patients. This is achieved through the development of new drugs and other innovative approaches, and the testing of more effective therapeutic strategies, using currently approved drugs, surgery and/or radiotherapy in clinical trials conducted under the auspices of a vast network of clinical cancer researchers supported by 220 staff members based in Brussels. EORTC has the expertise to conduct large and complex trials especially specific populations such as the older patient and rare tumours.

Royal Surrey County Hospital Hospital in England

The Royal Surrey County Hospital (RSCH) is a 520-bed District General Hospital, located on the fringe of Guildford, run by the Royal Surrey NHS Foundation Trust.

James Lewis Abbruzzese is the Chief of the Duke Division of Medical Oncology and Associate Director for Clinical Research for the Duke Cancer Institute. Previously, Abbruzzese was Chairman of the Department of Gastrointestinal Medical Oncology at the University of Texas M. D. Anderson Cancer Center where he held the M. G. and Lillie A. Johnson Chair for Cancer Treatment and Research and the Annie Laurie Howard Research Distinguished Professorship. Abbruzzese is one of the world's leaders in the clinical study and treatment of pancreatic cancer.

Jonathan J. Lewis, M.D., Ph.D., is a surgeon, biomedical researcher and entrepreneur. He was trained in surgery in South Africa, Britain, and the United States, and is a fellow of both the Royal College of Surgeons and the American College of Surgeons. Dr. Lewis was awarded an MB.B.Ch. from University of the Witwatersrand School of Medicine, and his Ph.D. in Molecular Biology from Witwatersrand and Yale School of Medicine. He completed his Surgical Residency at Charlotte Maxeke Johannesburg Academic Hospital and at Yale-New Haven Hospital. Lewis was a Professor of Surgery and Medicine Memorial Sloan-Kettering Cancer Center, before working in the biotechnology industry, first as chief medical officer of RubyConn, then as chairman and chief executive officer of ZIOPHARM Oncology, Inc. He was chief executive officer of Samus Therapeutics and is currently chairman of the Molecular Ninja Group and chief executive officer of Varian Biopharma.

The Pancreatic Cancer Action Network (PanCAN) is a United States-based 501(c)(3) charity that funds research, provides patient/caregiver support, conducts community outreach and advocates for increased federal research funding for those affected by pancreatic cancer.

Gregory Bruce Mann is a surgical oncologist and Director of Breast Cancer Services at the Royal Women's Hospital in Melbourne, Australia, the largest specialist women's care hospital in Australia. A former president of COSA, Dr. Mann served previously as Director of Cancer Services and Infectious Medicine for the Melbourne Health Cancer Service, as Director of the award-winning Melbourne Health Combined Breast Service and is Director of Advanced Surgical Training at the Royal Melbourne Hospital. The Combined Breast Service won the prestigious Premier's Award for "Excellence for improving cancer care in Victoria" under Mann's direction in 2008.

Christopher M. Nutting is a British Professor of Clinical Oncology and medical consultant, specializing in head and neck cancers, who has helped develop Intensity-Modulated Radiotherapy (IMRT), an advanced form of Radiation therapy.

Rajendra Achyut Badwe, is an Indian medical doctor and surgical oncologist. He was honoured by the Government of India, in 2013, by bestowing on him the Padma Shri, the fourth highest civilian award, for his contributions to the field of medicine.

Steven Clark Cunningham is an American surgeon. He is known for dealing with medical conditions relating to pancreatic, biliary, and liver surgery.

Darab Jehangir Jussawala (1915–1999) was an Indian medical-cum-surgical oncologist, medical writer and the director of Tata Memorial Centre. He was the co-founder of Indian Cancer Society, along with Naval Tata in 1951, and the founder of the Indian Cancer Rehabilitation Centre in Parel, Mumbai, in 1956, the first such centre in India and the largest in Asia. He served as the director of Lady Ratan Tata Medical and Research Center and as the honorary consultant at two Mumbai hospitals, Breach Candy Hospital and Jaslok Hospital. An elected fellow of the Royal Society of Medicine, National Academy of Medical Sciences, Indian Academy of Sciences, Indian National Science Academy and the American College of Surgeons, he was a recipient of the Dhanwantari Award as well as several Oration Awards. The Government of India awarded him the third highest civilian honour of the Padma Bhushan, in 1975, for his contributions to Medicine.

The 2016 Queen's Birthday Honours are appointments by some of the 16 Commonwealth realms of Queen Elizabeth II to various orders and honours to reward and highlight good works by citizens of those countries. The Birthday Honours are awarded as part of the Queen's Official Birthday celebrations during the month of June. The Queen's Birthday Honours were announced on 6 June 2016 in New Zealand and 10 June in the United Kingdom.

Yu Baofa is a Chinese oncologist and researcher in intratumoral cancer therapy and drug development. He is the Founder, CEO and Chairman of Baofa Cancer Hospital Network China in Jinan, Beijing and Dongping. He also developed Ultra Minimum Incision Personalized Intra-Tumoral Chemo-Immuno (UMIPIC) Therapy.

Andrew Victor Biankin is a Scotland-based Australian clinician-scientist, best known for his work on enabling precision oncology in learning healthcare systems by integrating discovery, preclinical and clinical development to accelerate novel therapeutic strategies, and developing standardised pan-cancer assays for use by healthcare systems and researchers worldwide.

Patrick Stewart Boulter FRCS, FRCSEd was a general surgeon in Guildford, England. He developed a sub-speciality interest in breast surgery and was one of the pioneers in the UK of screening for breast cancer. He served as president of the Royal College of Surgeons of Edinburgh from 1991 to 1994.

Emilia Dauway MD, FACS, FRACS is an American trained surgeon who is practicing general, breast and oncologic surgery in Australia. Dauway was co-inventor of the use of radioactive seeds in the breast to localise non-palpable breast cancers and the first in Australia to use magnetic seeds instead of radioactive seeds. This technique replaces hookwire or needle localisation improving patient safety, outcomes and satisfaction. The method was patented by the University of South Florida while Dauway was a fellow of surgical oncology. The method has been used since 1999 and has improved with the development of modern equipment. Dauway is also a Yoga Instructor, a Keynote speaker and is founder/director of Restore More, a non-profit initiative which provides education and funding to women in regional and geographically disadvantaged areas for breast cancer treatment and reconstruction.

References

  1. Stunt, Ali (August 30, 2012). "It's official – I'm now one of the 3% who survive pancreatic cancer". Pancreatic Cancer Action. Archived from the original on July 24, 2012. Retrieved February 24, 2013.
  2. "Five year analysis of the national cancer research database, 2002-2006" Archived 2011-07-21 at the Wayback Machine . National Cancer Research Institute. 2008.
  3. White et al., (1999) in Sultana et al. (2007). "Systematic review, including meta-analysis, on the management of locally advanced pancreatic cancer using radiation/combined modal therapy". British Journal of Cancer96: 1183-1190.
  4. "UK pancreatic cancer prognosis and survival rates". Pancreatic Cancer Action. Archived from the original on February 8, 2013. Retrieved February 24, 2013.

]